1,449
Views
2
CrossRef citations to date
0
Altmetric
Zoster

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy

, , , , , , , , , , , & show all
Article: 2288282 | Received 19 Aug 2023, Accepted 22 Nov 2023, Published online: 01 Dec 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Valentina Carta, Lucia Mangeri, Giorgio Tiecco, Emanuele Focà, Eugenia Quiros-Roldan & Maria Antonia De Francesco. (2024) Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review. Human Vaccines & Immunotherapeutics 20:1.
Read now

Articles from other publishers (1)

Minako Yamaoka-Tojo & Taiki Tojo. (2024) Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination. Vaccines 12:3, pages 252.
Crossref